Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2023 Sep-Oct;79(5):500-505.
doi: 10.1016/j.mjafi.2023.03.010. Epub 2023 May 15.

Barriers to the effective management and prevention of post kala-azar dermal leishmaniasis (PKDL) in the Indian subcontinent

Affiliations
Review

Barriers to the effective management and prevention of post kala-azar dermal leishmaniasis (PKDL) in the Indian subcontinent

Biplab Pal et al. Med J Armed Forces India. 2023 Sep-Oct.

Abstract

Post kala-azar dermal leishmaniasis (PKDL) is a skin disease that usually occurs among individuals with a past history of visceral leishmaniasis (VL). PKDL cases act as a reservoir of parasites and may play a significant role in disease transmission. Hence, prompt detection and complete treatment of PKDL cases are crucial for the control and elimination of VL. The purpose of this review was to highlight the barriers to effective control and prevention of VL/PKDL as well as potential solutions in India. Main obstacles are lack of knowledge about the disease and its vector, poor treatment-seeking behaviours, ineffective vector control measures, lack of confirmatory diagnostics in endemic areas, limited drug choices, treatment noncompliance among patients, drug resistance, and a lack of an adequate number of trained personnel in the health system. Therefore, in order to control and successfully eliminate VL in the Indian subcontinent, early detection of PKDL cases, improved diagnosis and treatment, raising awareness, and effective vector control mechanisms are necessary.

Keywords: Challenge; Kala-azar; Post kala-azar dermal leishmaniasis; Visceral leishmaniasis elimination.

PubMed Disclaimer

Conflict of interest statement

The authors have none to declare.

Similar articles

Cited by

References

    1. Zijlstra E., Musa A., Khalil E., El Hassan I., El-Hassan A. Post-kala-azar dermal leishmaniasis. Lancet Infect Dis. 2003;3:87–98. - PubMed
    1. Topno R.K., Rabi Das V.N., Kumar M., et al. Public Library of Science; San Francisco, CA USA: 2020. Advanced Case of PKDL Due to Delayed Treatment: A Rare Case Report. - PMC - PubMed
    1. Garapati P., Pal B., Siddiqui N.A., et al. Knowledge, stigma, health seeking behaviour and its determinants among patients with post kalaazar dermal leishmaniasis, Bihar, India. PLoS One. 2018;13 - PMC - PubMed
    1. Kumar R., Das V.N.R., Topno R.K., et al. Para-kala-azar dermal Leishmaniasis cases in Indian subcontinent–A case series. Pathog Glob Health. 2016;110:326–329. - PMC - PubMed
    1. Ramesh V., Kaushal H., Mishra A.K., Singh R., Salotra P. Clinico-epidemiological analysis of Post kala-azar dermal leishmaniasis (PKDL) cases in India over last two decades: a hospital based retrospective study. BMC Publ Health. 2015;15:1–8. - PMC - PubMed

LinkOut - more resources